NEUSSERIA PERFLAVA ALLERGEN, METHOD TO PREDICT SENSITIVITY TO NEUSSERIA PERFLAVA AND METHOD OF IMMUNOTHERAPY IN PATIENTS WITH INFECTIOUS- ALLERGIC DISEASES Russian patent published in 2002 - IPC

FIELD: medicine, immunology. SUBSTANCE: Neusseria perflava allergen is suggested representing the mixture of phenol-inactivated microbial cells of "57" and "11" strains and products of their metabolism at 300-500 mln microbial cells/ml concentration, pH = 6.5-7.3. The present allergen could be used for specific diagnostics to Neusseria perflava and in immunotherapeutic methods in patients suffering infectious-allergic diseases. EFFECT: increased sensitivity level to Neusseria perflava and higher efficiency to conduct specific immunotherapy. 3 cl, 5 tbl